Year-end Sale % OFF 
Abstract
Aim. The aim of the study was to analyze the effect of benfotiamine (BFT) on the insulin resistance state, the content of some pro- and anti-inflammatory factors in patients with type 2 diabetes mellitus (T2DM) and advanced stage of cardiac autonomic neuropathy (CAN). Material and methods. 40 patients with T2DM and advanced stage of CAN, aged between 50-59 yrs with disease term 1-6 yrs and average glycated hemoglobin A1c (HbA1c) 7,16%±0,19% were examined. Patients were divided into 2 groups. The patients from first group received standard hypoglycemic treatment (n=19, control) for three mo. To patients from the second (n=21, treatment group) was prescribed 300 mg/q.d. of the BFT in addition for three mo. The levels of blood glucose, HbA1c, immunoreactive insulin (IRI), high sensitivity C-reactive protein (hs-CRP), leptin, tumor necrosis factor-alpha (TNF-alpha), interleukins (IL)-6, IL-8 and IL-10 were determined. The Homeostasis Model Assessment (HOMA) insulin resistance (IR) index (HOMA-IR) parameters, TNF-alpha/IL-10 ratio were calculated. Results. Treatment with BFT led to significant decrease in the concentration of IRI [Δ=-12,74%±1,42% (p 0,05). Conclusion. Obtained data may indicate a decrease in the activity of the proinflammatory link of the immune response and allow us to consider BFT as a promising pharmacological agent in the complex treatment of the advanced stage of CAN.
Highlights
Конфликт интересов: исследование проводилось в рамках научной работы Львовского национального медицинского университета им
The aim of the study was to analyze the effect of benfotiamine (BFT) on the insulin resistance state, the content of some pro- and anti-inflammatory factors in patients with type 2 diabetes mellitus (T2DM) and advanced stage of cardiac autonomic neuropathy (CAN)
immunoreactive insulin (IRI) concentrations and Homeostasis Model Assessment (HOMA)-insulin resistance (IR) parameters in patients with T2DM and advanced stage of CAN after 3-months of BFT therapy are given in table 1
Summary
Конфликт интересов: исследование проводилось в рамках научной работы Львовского национального медицинского университета им. AGEs — advanced glycation end-products, ANS — autonomic nervous system, BFT — benfotiamine, BMI — body mass index, CAN — cardiac autonomic neuropathy, CARTs — cardiovascular autonomic reflex tests, COX-2 — cyclooxygenase-2, DN — diabetic neuropathy, HbA1c — glycated hemoglobin A1c, HOMA-IR — Homeostasis Model Assessment (HOMA) insulin resistance (IR) index, hs-CRP — high sensitivity C-reactive protein, IL — interleukin, iNOS — inducible nitric oxide synthase, IRI — immunoreactive insulin, JNK — c-Jun N-terminal kinase, LPS — lipopolysaccharide, NF-κB — nuclear factor kappa-light-chain-enhancer of activated B cells, NO — nitric oxide, OS — oxidative stress, PKC — protein kinase C, T2DM — type 2 diabetes mellitus, TD — thiamine deficiency, TKT — transketolase, TNF-alpha — tumor necrosis factor-alpha, TNF-alpha/IL-10 — tumor necrosis factor-alpha/IL-10 — interleukin 10 ratio. Effects of benfotiamine on the insulin resistance state, some pro- and anti-inflammatory factors content in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
